MetaCap

Evotec (EVO) News

NASDAQ: EVOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.32-0.13 (-8.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

EVO news summary

We found 6 recent headlines mentioning Evotec (EVO): 3 in the past week and 4 in the past 30 days, most often from Nasdaq, PR Newswire. EVO is making an outsized move today, down 8.97% at $1.32, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Evotech & Bristol Myers Squibb Get IND Clearance For Second Molecular Glue Candidate", was published by Nasdaq on Nov 19, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Evotec headlines

Stocks mentioned alongside EVO

Compare EVO